In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...
More »SEARCH RESULT
Total Matching Records found : 49
CAG Vinod Rai to head UN audit panel
-The Times of India The Centre has been critical of the Comptroller and Auditor General (CAG) for taking out a series of adverse findings on government policies, but the contribution of the apex auditor seems to have been recognized by the United Nations which has appointed CAG Vinod Rai as chairman of its panel of external auditor. Rai as chairman will oversee the audit of the International Atomic Energy Agency (IAEA), besides...
More »UN urges greater appreciation of indigenous culture and creativity
-The United Nations Secretary-General Ban Ki-moon today urged the world to recognize the right of indigenous peoples to control their intellectual property, saying they needed help to protect, develop and receive fair compensation for their cultural heritage and traditional knowledge. “Indigenous peoples face many challenges in maintaining their identity, traditions and customs, and their cultural contributions are at times exploited and commercialized, with little or no recognition,” Mr. Ban said in a...
More »Farm IP, Enter WIPO by Latha Jishnu
Developing countries will now have to battle IP issues related to new agricultural technologies at WIPO instead of WTO The World Intellectual Property Organization has announced clearly that it intends to play a role—and considering the clout WIPO enjoys it implies a significant part—in promoting intellectual property (IP) in agriculture to enhance productivity. The UN body stepped into this touchy arena with a seminar at its Geneva headquarters that has gone...
More »UN welcomes pact to improve access of patented AIDS drugs in poor countries
-The United Nations The United Nations agency mandated to spearhead the global response to HIV/AIDS today welcomed the new license agreement between the Medicines Patent Pool and the pharmaceutical company Gilead Sciences to increase access to antiretroviral therapy in developing countries. The Joint UN Programme on HIV/AIDS (UNAIDS) said the agreement marks the first time a pharmaceutical company has signed an agreement with the Medicines Patent Pool, describing it as a turning...
More »
